|
|
|
| |
|
|
| |
The latest lab automation and artificial intelligence news from AZoNetwork |
|
|
|
| |
Is Your Lab Automation Partner Good Enough?
Choosing the right robotic automation partner is more important than choosing the right robot. New research from METTLER TOLEDO and ABB Robotics reveals what separates successful lab automation projects from stalled ones - from pilot design and stakeholder alignment to integration, support, and long-term scalability. Download part 3 of the free white paper series
| |
|
|
| |  | | | Researchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, identifying five core targets: ADRB2, BCL3, EGR1, FOS, and MAP3K8. In rats, palmatine improved liver injury, inflammation, oxidative stress, glycolipid metabolism, steatosis, and fibrosis, while reducing apoptosis-related signaling, providing a preclinical foundation for further therapeutic study. | | | | | Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and limited responses to immunotherapy in most patients. | | | | | Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related adverse events remain a major concern. | | | | | A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research published in Genes & Disease. | | | | | Why do some species live for only weeks while others survive for centuries? Researchers at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena have developed AEGIS, a freely available software tool that enables scientists to simulate evolution on a standard computer and investigate how lifespan and aging evolve under different ecological pressures and genetic constraints. | | | | | A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. | | | | | Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients. | | | | | A research team under the direction of the Medical University of Vienna has identified a potential new method for drug development in a recently published review. | | | | | By analyzing intact proteins, top-down proteomics uncovers proteoforms that influence disease, aiding in biomarker discovery and therapeutic targeting. | |
|
|
| | | How would you rate today's newsletter?
| |
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|